8MW 0511
Alternative Names: 8MW-0511; MW-05; Recombinant (yeast secreted) human serum albumin-human granulocyte colony stimulating factor (I) fusion protein - Mabwell (Shanghai) BioscienceLatest Information Update: 21 Dec 2023
At a glance
- Originator Mabwell (Shanghai) Bioscience
- Class Albumins; Granulocyte colony-stimulating factors; Recombinant fusion proteins
- Mechanism of Action Granulocyte colony-stimulating factor replacements; Haematopoiesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preregistration Neutropenia
Most Recent Events
- 19 Dec 2023 Preregistration for Neutropenia (Prevention, Chemotherapy-induced) in China (SC)
- 23 Oct 2023 Mabwell (Shanghai) Bioscience announces intention to submit NDA for Neutropenia in 2023
- 20 Oct 2023 Efficacy and adverse events data from the phase II trial in Gastric cancer presented at the 48th European Society for Medical Oncology Congress (ESMO-2023)